Clinical Trials Browser

Phase 2 × Completed × UNKNOWN × Clear all

Stomach Neoplasms

NCT04247984 2022-03-11

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Phase 2 Completed

264 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02992886 2021-09-09

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

Phase 2 Completed

68 enrolled

Gastrointestinal

Rectal Neoplasms

NCT01463605 2021-02-04

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Phase 2 Completed

46 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03083613 2021-02-01

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 2 Completed

41 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03535961 2020-12-02

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Phase 2 Completed

32 enrolled

Breast

Breast Neoplasms

NCT04002284 2020-07-29

Anlotinib in Metastatic HER2 Negative Breast Cancer

Phase 2 Completed

26 enrolled

Breast

Breast Neoplasms

NCT01187238 2020-07-16

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

Phase 2 Completed

84 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03572829 2020-07-15

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Phase 2 Completed

44 enrolled

Head & Neck

Head and Neck Neoplasms, Vomiting

NCT02301481 2019-10-16

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

Phase 2 Completed

71 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01520324 2019-02-08

Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

Phase 2 Completed

53 enrolled 13 charts

Colitis, Ulcerative

NCT02295774 2018-11-05

Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA

Phase 2 Completed

10 enrolled 6 charts

Gastrointestinal

Colorectal Neoplasms

NCT02276248 2017-08-16

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

Phase 2 Completed

40 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT02460744 2015-06-02

2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer

Phase 2 Completed

50 enrolled

Breast

Breast Neoplasms

NCT02133612 2015-04-14

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Phase 2 Completed

43 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02370849 2015-02-25

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

Phase 2 Completed

2 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02323737 2014-12-30

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

Phase 2 Completed

62 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT01531452 2014-12-04

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

Phase 2 Completed

43 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01797900 2014-09-10

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Phase 2 Completed

130 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT01444521 2014-05-06

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

Phase 2 Completed

50 enrolled

Gastrointestinal

Stomach Neoplasms

NCT00600587 2013-06-25

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

24 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

MATCH

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Anlotinib in Metastatic HER2 Negative Breast Cancer

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)